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Menopause is referring to end of reproductive period and starting of aging 
problems due to lack of ovarian hormones. There is no direct reference found in 
Ayurveda regarding menopause but Jaravastha can be correlated as 
Rajonivrittijanya Lakshanas. Rasayana drugs promote the regeneration of 
Dhatus, intelligence, mental wellbeing, immunity and longevity. So, Rasayana 
drugs are helpful to decrease aging related problems. Aim: Present study has 
been planned to evaluate the efficacy of Vayasthapana Gana having Rasayana 
effect on menopausal syndrome. Materials and methods: Total 18 known cases 
of menopausal syndrome patients in the age group between 45-55 years, 
minimum one year after cessation of menses were selected for the study, out of 
which 16 patients completed the treatment. Vayasthapana Gana Ghanavati 2 
tablets (500mg each) were administered twice a day with milk for duration of 
two months with follow up period of one month. Improvement was monitored as 
per Menopausal Rating Scale. Result: 13 (81.25%) patients showed mild 
improvement and 3 (18.75%) patients had moderate improvement. No any 
significant changes were observed in serum follicle stimulating hormone and 
serum oestradiol and other laboratory findings. The score of menopausal rating 
scale was decreased from 27.50 to 14.75 after the treatment. Conclusion: 
Vayasthapana Gana Ghanavati is safe and effective in the management of 
menopausal syndrome. 
INTRODUCTION
 Menopause means permanent cessation of 
menstruation and ending of young age due to deficiency 
of hormone i.e., oestrogen which is denoted as female 
hormone. Menopause is the time when last and final 
menstruation occurs[1]. Though menopause is a 
physiological phenomenon many psychological changes 
occur those are not considered as disease condition, 
affecting multisystem and manifested with various 
symptomatology known as menopausal syndrome. This 
period usually occurs after 40 years[2] in most of the 
women.  
 Menopause is an estrogen deficient phase of 
women’s life which accelerates the ageing process 
resulting greater vulnerability to psychosomatic 
problems and make her life dependent. Characteristic 
features are hot flushes, bouts of rapid heartbeat, sleep 
disturbances, mood swings, night sweating, disturbing 
memory lapses, developing senile vaginitis due to dry 
vagina, loss of libido and osteoporosis etc. Variation in 
premenopausal phase leads to mood swing, depression, 
anxiety, obesity, hypertension, diabetes mellitus and 
cancer are more prone in menopausal women that need 
medical help. So in order to bring the women back in 
their independent routine life, this physiological stage 
invites attention of physicians to think over it. In India, 
menopausal population is increasing day by day and 
women suffering from menopausal syndrome are also 
increasing because of fast and stressful life in modern 
era. Menopausal symptoms increased more in this era 
because of empty nest syndrome[3] i.e. feeling of 
loneliness due to marriage of their children. Traditionally 
Indian women worked within family so, stress found 
only at emotional level, severity of menopausal 
symptoms may not found, but now in modern era, 
women need to perform both familial as well as 
professional life as severity of symptoms found more. 
There is no direct reference regarding menopause in 
Ayurveda but we can correlate with “Jarapakvavastha” 
mentioned by Sushruta. Jarapakvavastha[4] in female is 
widely known as Rajonivrittikala (menopausal stage). 
Rasayana Chikitsa (Rejuvenation therapy) is the unique 
therapy contributed by Ayurveda particularly effective in 
reducing the aggravating clinical features and problems 
during old age. Rasayana[5] nourishes and increases the 
immunity, keeps the body young and helps to promote 
healthy long life. Rasayana endowed with psychic 
excellence like sharp memory. All the drugs in 
Vayasthapana Gana[6] are having Rasayana properties 
and is indicated to restore the Vaya (youngness). So 
Vayasthapana Gana was selected for the present study to 
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evaluate the efficacy of Vayasthapana Gana Ghanavati on 
various features of menopausal syndrome. 
Materials and Methods 
 Total 18 patients fulfilling the selection criteria 
were selected from the O.P.D. of Prasuti Tantra and Stree 
Roga Department. Two patients were dropped out due to 
their personal reasons. 
Table 1: Total registration of patients 
Registered Completed  Dropped out 
18 16 2 
1) Study was started after obtaining Ethical clearance 
from the Institutional Ethics Committee. (7/-
A/Ethics/2013-2014/1767, 10/09/2013). 
2) Study has been registered in CTRI (CTRI Reg. No: 
CTRI/2015/07/006044). 
Inclusion criteria 
1) Age group between 40-55 years suffering from 
menopausal syndrome. 
2) Amenorrhea at least for 12 months or more. 
3) FSH ≥ 20 IU/L 
4) Endometrial thickness ≤ 5 mm by USG finding. 
Exclusion criteria 
1) Age below 40 years and age more than 55 years. 
2) Women with uncontrolled medical conditions e.g. 
hypertension, heart disease, diabetes mellitus, 
cancer. 
3) Patients having the h/o hormone replacement 
therapy (HRT). 
4) Established case of mental illness. 
Investigations: (before and after treatment) 
 Fasting blood sugar, S.Creatinine, S. Cholesterol, 
S.Triglyceride, High-density lipoprotein (HDL), 
S.Cholesterol/ HDL ratio. 
 S. Oestradiol and S. Follicle stimulating hormone. 
 Ultra Sonography - TVS (Transvaginal sonography) 
(before treatment). 
Study type and duration 
Open level clinical trial 
 Vayasthapana Gana Ghanavati 2 tablets (500mg 
each) twice a day was administered for two months with 
milk before meal with follow up of one month. 
Table 2: Ingredients of Vayasthapana Gana Ghanavati 
No Name of Drug Botanical name (Latin name) Part used Part 
1. Guduchi Tinospora cordifolia Willd. Stem 1 
2. Haritaki Terminalia chebula Retz. Dried Fruit 1 
3. Amlaki Emblica officinalis Gaertn. Dried Fruit 1 
4. Rasna Pluchea lanceolata C.B.Clarke Root 1 
5. Aparajita Clitoria ternetia Linn. Whole plant  1 
6. Jeevanti Leptadenia reticulate W&A. Stem and leaves 1 
7. Shatavari Asparagus racemosus Willd. Root 1 
8. Mandukparni Centella asiatica Linn. Whole plant  1 
9. Shalparni Desmodium gangeticum D.C. Whole plant  1 
10. Punarnnava Boerhaavia diffusa Linn. Whole plant  1 
Criteria of assessment 
1) Subjective criteria 
The result was assessed on as per Menopausal Rating 
Scale (MRS).  
 In MRS, there are 11 characteristic features of 
menopausal syndrome and are divided into three 
subscales: (1) Somatic scale includes hot flushes, 
palpitation, sleeping problems and muscle and joint 
problems; (2) Psychological scale includes depressive 
mood, irritability, anxiety and physical and mental 
exhaustion and (3) Urogenital scale includes sexual 
problems, bladder problems and dryness of vagina. 
Grading pattern is taken i.e. 0= No symptoms, 1= Mild, 2= 
Moderate, 3= Severe, 4= Very Severe. 
2) Objective criteria 
S. Cholesterol, S. Triglyceride, HDL, S. Cholesterol /HDL 
S. Creatinine  
S.FSH, S. Oestrodiol 
Criteria for assessment of therapy 
The overall effect of therapy was assessed as follows: 
1. Complete cured - 100% relief. 
2. Marked improvement - 76% - 99% relief.  
3. Moderate improvement - 51% - 75% relief. 
4. Mild improvement - 26% - 50% relief. 
5. Unchanged - Up to 25% relief. 
Statistical analysis 
 The values were expressed as percentage of 
relief and mean, SEM (Standard Error Mean). MRS and 
both subjective and objective parameters were analyzed 
by applying students paired ‘t’ test in sigma stat 
software. 
Result and Discussion 
General Observations (n=18) 
 In the present study, maximum 50 % of patients 
were from the age group between 46-50 years, 77.77% 
of patients had menopause for last 1- 5 years, 94.44% 
were married, 61.11% were from nuclear family, 44.44% 
patients were complaining of constipation, Vatapitta 
Prakriti was observed in 83.33% of patients, 81.25% of 
patients were having increased BMI (>25), While asking 
for Nidana Sevana (predisposing/aggravating factors) i.e. 
Ratrijagarana (Awaking at night), Divaswapna (Day 
sleep), Alasya (Laziness) and Katu-Amla Rasa Aharas 
Sevana (Use of excessive hot and sour diet) were 
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observed in maximum patients i.e. 72.22%, 33.33%, 
55.55% and 77.77% respectively; while Avyayama (Lack 
of exercise) was observed in 66.66 %. 
Observations on MRS 
Table 3: Observations on Somatic sub score 
Symptoms n=18 No. of Patients % 
Hot flushes  
None 1 5.56 
Mild 0 00 
Moderate 5 27.78 
Severe 6 33.33 
Very Severe 6 33.33 
Palpitation 
None 2 11.11 
Mild 3 16.66 
Moderate 12 66.66 
Severe 0 00 
Very Severe 1 5.56 
Sleep Problems 
None 3 16.66 
Mild 1 5.56 
Moderate 2 11.11 
Severe 7 38.88 
Very Severe 5 27.78 
Table 4: Observations on Psychological sub score 
Depressive Moods 
None 2 11.11 
Mild 1 5.56 
Moderate 6 33.33 
Severe 8 44.44 
Very Severe 1 5.56 
Irritability 
None 0 00 
Mild 0 00 
Moderate 10 55.55 
Severe 7 38.89 
Very Severe 1 5.56 
Anxiety 
None 1 5.56 
Mild 1 5.56 
Moderate 6 33.33 
Severe 9 50 
Very Severe 1 5.56 
Table 5: observation on Urogenital sub score 
Physical & Mental Exhaustion 
None 0 00 
Mild 0 00 
Moderate 1 5.56 
Severe 14 77.77 
Very Severe 3 16.67 
Sexual Problems 
None 3 16.67 
Mild 1 5.56 
Moderate 3 16.67 
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Severe 10 55.55 
Very Severe 1 5.56 
Bladder Problems 
None 1 5.56 
Mild 1 5.56 
Moderate 2 11.11 
Severe 9 50 
Very Severe 5 27.78 
Vaginal Dryness 
None 3 16.67 
Mild 1 5.56 
Moderate 5 27.78 
Severe 8 44.44 
Very Severe 1 5.56 
Joint & Muscular discomfort 
None 0 00 
Mild 0 00 
Moderate 4 22.22 
Severe 12 66.67 
Very Severe 2 11.11 
Table 6: Effect of Vayasthapana Gana Ghanavati on Menopausal Rating Scale 
Symptoms n Mean ± SEM Mean 
Diff 
% relief ‘t’ ‘P’ 
BT AT 
Hot flushes, Sweating  15 3.133±0.215 1.067±0.118 2.067 ↓ 53.957 11.374 <0.001 
Palpitation 15 1.933±0.182 1.067±0.067 0.867 ↓44.827 6.5 <0.001 
Sleep Problems  14 2.857±0.312 1.429±0.173 1.429 ↓50 7.071 <0.001 
Depressive Mood  14 2.571±0.646 1.357±0.133 0.214 ↓47.222 5.667 <0.001 
Irritability  16 2.438±0.128 1.125±0.085 1.313 ↓53.846 8.720 <0.001 
Anxiety  14 2.571±0.173 1.286±0.125 1.286 ↓50 5.264 <0.001 
Physical & Mental 
Exhaustion  
16 3.063±0.111 1.438±0.128 1.625 ↓53.061 10.498 <0.001 
Sexual problems  13 2.769±0.201 2.154±0.296 0.615 ↓22.222 3.411 <0.01 
Bladder problems  15 3±0.218 1.4±0.19 1.6 ↓53.333 8.411 <0.001 
Vaginal Dryness  13 2.692±0.208 2±0.277 0.692 ↓25.714 3.323 <0.01 
Joint and muscular 
discomfort 
16 3±0.129 1.938±0.143 1.063 ↓35.416 5.506 <0.001 
Total 16 27.5±1.336 14.75±0.977 12.75 ↓46.363 13.053 <0.001 
Table 7: Result on subscales 
Sub score n Mean ± SEM Mean 
Diff 
% relief ‘t’ ‘P’ 
BT AT 
Somatic sub score 16 10.25±0.602 5.188±0.277 ↓5.063 49.390 10.989 <0.001 
Psychological sub Score 16 10±0.612 4.875±0.375 ↓5.125 51.25 9.373 <0.001 
Urogenital sub score 15 7.333±0.613 5±0.625 ↓2.733 35.345 5.909 <0.001 
Table 8: Effect of therapy on laboratory investigations 
Investigations 
 
n Mean Mean 
Diff. 
% Change S.E. T P 
B.T. A.T. 
S. Cholesterol 16 179.88 189.44 -9.563 ↑ 5.32 4.625 -2.068 >0.05 
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S. Triglyceride 16 155.69 143.63 -27.94 ↓ 24.15 32.30 -0.865 >0.05 
HDL 16 55.81 57.5 -1.987 ↑ 5.85 1.829 -1.629 >0.05 
S. Cholesterol /HDL  16 3.253 3.325 -0.073 ↑ 2.229 0.109 -0.663 >0.05 
S. Creatinine 16 0.94 0.86 0.075 ↓ 8 0.035 2.158 <0.05 
S.FSH 16 67.15 67.668 -0.519 ↑ 0.77 11.337 -0.046 >0.05 
S. Oestrodiol 16 106.9 103.67 3.235 ↓ 3.026 6.671 0.485 >0.05 
         
 After treatment, no significant changes were 
observed in the biochemical and hormonal values. 
 Menopause is a part of aging process of women’s 
life. The majority of the symptoms of menopause are due 
to Mandagni, Dhatukshayavastha, Vata Vriddhi and 
Manovaha Srotasdushti (channels that connect the mind 
to the senses). Rasayana therapy seems to be line of 
treatment, to nourish the Dhatus. However Rasayana is 
not a complete cure for Rajonivritti Janya Lakshanas/ 
menopausal syndrome. It can only delay the process of 
aging and symptomatically relieve the menopausal 
discomforts for some time and also prevent the adverse 
effects in the post menopausal period. 
Probable mode of action of Vayasthapana Gana 
Ghanavati 
 Most of the drugs have Tikta, Madhura and 
Kashaya Rasa Pradhana and having Madhura Vipaka, 
Tikta, Kashaya Rasa are Pittashamaka and also balance 
Kapha Dosha. Madhura Rasa having soothing effect 
promotes strength and pacifies Pitta and Vata Dosha. So, 
Vayasthapana Gana Ghanavati works as Tridosha 
Shamaka and reduce the Rajonivrittijanya Lakshanas by 
balancing Tridhosha. Tikta Rasa has direct action on 
promotion of Medha (Memory). Most of the drugs in 
Vayasthapana Gana Ghanavati have Deepana, Pachana 
property which improves the status of Agni. 
Vayasthapana Gana Ghanavati has properties of 
Vayasthapana, Balya (Tonic) and Rasayana which 
promote proper formation of Rasa Dhatu. Besides these 
properties, most of the ingredients helps in delaying the 
aging process and reduce the somatic symptoms of 
menopause. Amalaki, Shatavari, Jatamansi, Mandukparni, 
Guduchi, Shalparni and Punarnava have Hridya property 
and Amalaki, Shatavari, Jatamansi, Mandukparni, 
Haritaki, Jivanti have Medhya (promote intellect) 
property which help to reduce psychological symptoms 
of menopause. Punarnava, Jivanti and Satavari have 
Mutrala (Diuretic) properties which reduce the bladder 
problems. Antioxidant property of Guduchi[8], Haritaki[9], 
Amalaki[10], Aparajita[11] and Mandukparni[12] which helps 
to block or slow down a variety of neurodegenerative 
processes. Anti stress, adoptogenic activity of Punarnava 
[13], anti-anxiety and anti-depressant activity of 
Mandukparni and cardio protective activity of Amalaki 
and Guduchi helps to reduce psychological symptoms of 
menopause. Phytoestrogenic activity of Shatavari [14] also 




Table 9: Overall effect of therapy (n= 16) 
Effect of therapy No. of 
patients 
% 














 Vayasthapana Gana Ghanavati proving 
encouraging results in somatic complaints i.e. hot 
flushes, physical and mental exhaustion, bladder 
problems, joint and muscular discomfort and 
psychological complaints i.e. palpitation, sleep problems, 
depressive mood, irritability, anxiety. Vayasthapana 
Gana Ghanavati is administered for 60 days significantly 
decreased the severity of menopausal symptoms. The 
score of menopausal rating scale was decreased from 
27.50 to 14.75 after the treatment. Hence, Vayasthapana 
Gana Ghanavati can be recommended in the menopausal 
syndrome. 
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